Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
Forty-one researchers from MSK and the Sloan Kettering Institute (SKI) are recognized on this year’s list for demonstrating significant influence in their chosen fields by publishing multiple highly cited papers in their areas of expertise during the past decade. These papers are deemed to be the most scientifically impactful and are ranked in the top 1% by citations for their field and year (the definition of a highly cited paper).
“For more than 135 years, MSK scientists and physicians have been relentlessly focused on understanding the mechanisms of cancer. These breakthroughs fuel our research teams to push forward and discover more effective ways to diagnose and treat cancer, transforming outcomes for patients around the world,” said Selwyn M. Vickers, M.D., FACS, President and CEO of MSK. “We applaud those in our MSK community who were named to the 2022 Highly Cited Researchers list, along with the teams supporting them, and are grateful for their commitment to our mission on behalf of all of the patients and families we serve.”
“Our scientists’ expertise and pursuit of knowledge has answered some of the most difficult questions about cancer,” said Joan Massagué, PhD, Director, SKI. “I am proud of our outstanding individuals and teams whose work inspires fellow scientists and profoundly influences the field of cancer science at large. We congratulate them on this well-deserved honor.”
The following researchers are recognized on the 2022 Highly Cited Researchers list:
- Maria E. Arcila, MD
- Michael F. Berger, PhD
- Alexander Drilon, MD
- Clifford A. Hudis, MD
- Mark G. Kris, MD
- Marc Ladanyi, MD.
- Robert J. Motzer, MD
- Michael A. Postow, MD
- Gregory J. Riely, MD, PhD
- Charles M. Rudin, MD, PhD
- William D. Travis, MD
- Jedd D. Wolchok, MD, PhD*
- Margaret K. Callahan, MD, PhD
- Sarat Chandarlapaty, MD, PhD
- Justin Cross, PhD
- Elisa de Stanchina, PhD
- Mithat Gönen, PhD
- Xuejun Jiang, PhD
- Luis Diaz Jr., MD
- Ross L. Levine, MD
- Ming Li, PhD
- Ingo K. Mellinghoff, MD, FACP
- Taha Merghoub, PhD*
- Natasha Rekhtman, MD, PhD
- Neal Rosen, MD, PhD
- Jonathan E. Rosenberg, MD
- Michel Sadelain, MD, PhD
- Charles L. Sawyers, MD
- Howard I. Scher, MD
- Nikolaus Schultz, PhD
- David B. Solit, MD
- Ying Taur, MD, MPH
- Agnès Viale, PhD
- Frederic Geissmann, MD, PhD
- Alexander Rudensky, PhD
- Marcel R.M. van den Brink, MD, PhD
- Omar Abdel-Wahab, MD
- Christine A. Iacobuzio-Donahue, MD, PhD
- Joan Massagué, PhD
- Dana Pe’er, PhD
- Craig B. Thompson, MD
*As of September 2022, Dr. Wolchok and Dr. Merghoub are no longer at MSK.
The full 2022 Highly Cited Researchers list can be found online here. Clarivate uses both quantitative and qualitative analysis to identify individuals from across the globe who have demonstrated significant and broad influence in their chosen field or fields of research. Full methodology can be found online here.